Business Wire

IPSOFT

6.10.2016 06:05:03 CEST | Business Wire | Press release

Share
IPsoft’s Cognitive Agent Amelia Takes on Pioneering Role in Banking with SEB

IPsoft announced today that one of Sweden’s largest banks, SEB will integrate Amelia into its customer service operations around year end. The Swedish bank will be the first in the industry to embrace IPsoft’s cognitive technology in order to deliver an enhanced customer experience for its million-strong client base in Sweden using local language. The decision to place Amelia in the front office builds on the successful first phase deployment of Amelia in an internal IT Service Desk supporting SEB’s 15,000 strong workforce.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161005006546/en/

By employing Amelia, the bank is accelerating progress towards its innovation goals and differentiating its service from others in the market. “Customer service is a key differentiator. By making Amelia available to respond to queries, we enhance our customers’ flexibility of receiving individualized support at a time that suits them and without any delays in response,” said Rasmus Järborg, SEB’s Chief Strategy Officer. “Our confidence in the positive experience Amelia can offer customers is built on the success of our internal programme to employ Amelia as an IT Service Desk agent. Within the first three weeks, she held over 4000 conversations with 700 users and was able to resolve the majority of those queries independently, allowing employees to get consistent support without delay.”

IPsoft will also help SEB set up its own cognitive centre of excellence in order to build an in-house talent pool of individuals who can mentor Amelia. They will supervise her learning, monitor her performance and identify new opportunities for applying this technology to re-shape customer journeys. This initiative sets a new standard for enterprises that are adapting their skills base to optimize the adoption of cognitive technology.

“Digital labor will provide a fundamental shift in the way that banks manage their operations and provide a platform on which it is possible to launch new services. The burden of guaranteeing compliance adherence, for example, could become a thing of the past as virtual agents never deviate from regulations and provide a full audit trail of every interaction. SEB is clearly a frontrunner in understanding the potential of digital transformation and seizing first mover advantage by placing Amelia in the front lines of its business,” said Chetan Dube, CEO IPsoft.

IPsoft’s Amelia is an artificial intelligence platform designed to problem-solve like a human, but in a fraction of the time. Built with semantic understanding, Amelia interacts with customers through natural language and even senses emotions. Unlike any other virtual agent, Amelia understands the full context of the dialogue, and applies logic to her knowledge of the subject matter in order to determine the right answer or best course of action.

About IPsoft

IPsoft automates IT and business processes for enterprises across a wide range of industries through the use of digital labor. Through its portfolio of world leading autonomic and cognitive solutions it provides services that allow its clients to secure competitive advantage. Headquartered in New York City, IPsoft has 18 offices in 15 countries across the world and serves more than 500 of the world’s leading brands directly as well as more than half of the world’s largest IT services providers.

To learn more about IPsoft’s solutions please visit www.ipsoft.com .

About SEB

SEB is a leading Nordic financial services group with a strong belief that entrepreneurial minds and innovative companies are key in creating a better world. SEB takes a long term perspective and supports its customers in good times and bad. In Sweden and the Baltic countries, SEB offers financial advice and a wide range of financial services. In Denmark, Finland, Norway and Germany the bank's operations have a strong focus on corporate and investment banking based on a full-service offering to corporate and institutional clients. The international nature of SEB's business is reflected in its presence in some 20 countries worldwide. At 30 June 2016, the Group's total assets amounted to SEK 2,677 billion while its assets under management totaled SEK 1,657 billion. The Group has around 15,500 employees. Read more about SEB at www.sebgroup.com .

Contact:

SEB
Laurence Westerlund, +4687638627
Press Officer, SEB
Laurence.westerlund@seb.se
or
IPsoft
Daniela Zuin, +001 212 708 5521
Marketing Director, IPsoft
daniela.zuin@ipsoft.com
or
Edelman for IPsoft
EMEA
David Mercer, +44 203 047 4160
David.Mercer@edelman.com
or
USA
Erin Pace, +1-312-297-6900
Erin.Pace@edelman.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye